What Widal test titer thresholds are considered diagnostic for typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Widal Test Titers for Typhoid Fever Diagnosis

The Widal test should NOT be used as the primary diagnostic tool for typhoid fever, as serologic evidence alone is insufficient for diagnosis according to CDC guidelines; blood culture isolation of Salmonella typhi is required for confirmation. 1

Guideline-Based Diagnostic Approach

Isolation of S. typhi from blood, stool, or other clinical specimens is the only acceptable laboratory criterion for confirmed typhoid fever diagnosis. 1 The CDC explicitly states that serologic evidence alone is not sufficient for diagnosis, and asymptomatic carriage should not be reported as typhoid fever. 1

When Widal Testing Must Be Used (Resource-Limited Settings)

If blood culture is unavailable and Widal testing must be employed, the following thresholds represent the best available evidence:

Optimal Diagnostic Titers

  • Anti-H (TH) agglutinin ≥1:80 provides the best balance of sensitivity (75%) and specificity (98%) in endemic areas, though positive predictive value remains poor at 26%. 2

  • Anti-O (TO) agglutinin ≥1:200 OR Anti-H ≥1:100 together correctly diagnose 74% of culture-positive cases, but this approach still yields 14% false-positives and 10% false-negatives. 3

  • In highly endemic regions, titers of ≥1:320 may be necessary to reduce false-positives due to elevated baseline antibody levels in the general population. 4

Critical Performance Limitations

  • The Widal test has extremely poor positive predictive value (26-54%) even at optimal cutoffs, meaning most positive results are false-positives. 3, 5, 2

  • Baseline antibody titers in healthy populations range from 1:20 to 1:80 in endemic areas, making interpretation of single acute-phase titers unreliable. 6

  • Background seropositivity rates are substantial: 13.8-18.5% of healthy individuals show agglutination at standard cutoffs in endemic regions. 5

Common Pitfalls to Avoid

  • Never rely on a single Widal test alone - the test lacks sufficient specificity for definitive diagnosis without clinical correlation. 3, 7

  • Endemic area cutoffs differ dramatically from non-endemic areas - a titer of 1:40 that was appropriate in Papua New Guinea in 1987 became useless by 1992 as typhoid became endemic and population antibody levels rose. 8

  • Age, sex, and geographic region significantly affect test performance - standardized cutoffs cannot be universally applied. 7

  • Slide agglutination tests show poor agreement with tube titration (kappa = 0.066-0.225), making rapid screening methods unreliable. 4

Alternative Diagnostic Approaches

Typhidot-M demonstrates superior sensitivity (92.6%) compared to Widal (34.1%) for early diagnosis, particularly in the first week of illness (97% vs 24.2% positivity). 9, 10 However, this still does not replace the need for culture confirmation per CDC guidelines. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Widal agglutination titres in the diagnosis of typhoid fever.

West African journal of medicine, 2007

Research

The Widal test in the diagnosis of typhoid fever in the transvaal.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1981

Research

Typhidot M and Diazo test vis-à-vis blood culture and Widal test in the early diagnosis of typhoid fever in children in a resource poor setting.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.